Retrieve available abstracts of 37 articles: HTML format
Single Articles
June 2025
PRANGE S, Metereau E, Klinger H, Huddlestone M, et al Serotonergic dysfunction in patients with impulse control disorders in
Parkinson's disease.
Brain. 2025;148:2108-2121. PubMedAbstract available
May 2025
HONG H, Tozer DJ, Chen Y, Brown RB, et al Perivascular space dysfunction in cerebral small vessel disease is related to
neuroinflammation.
Brain. 2025;148:1540-1550. PubMedAbstract available
April 2025
LU K, Baker J, Nicholas JM, Street RE, et al Associations between accelerated forgetting, amyloid deposition and brain atrophy
in older adults.
Brain. 2025;148:1302-1315. PubMedAbstract available
February 2025
WIJESINGHE SS, Rowe JB, Mason HD, Allinson KSJ, et al Post-mortem validation of in vivo TSPO PET as a microglial biomarker.
Brain. 2025 Feb 26:awaf078. doi: 10.1093. PubMedAbstract available
EIFF B, Bullmore ET, Clatworthy MR, Fryer TD, et al Extra-axial inflammatory signal and its relationship to peripheral and central
immunity in depression.
Brain. 2025;148:635-646. PubMedAbstract available
WARMENHOVEN N, Salvado G, Janelidze S, Mattsson-Carlgren N, et al A comprehensive head-to-head comparison of key plasma phosphorylated tau 217
biomarker tests.
Brain. 2025;148:416-431. PubMedAbstract available
MALPETTI M, Swann P, Tsvetanov KA, Chouliaras L, et al Blood inflammation relates to neuroinflammation and survival in frontotemporal
lobar degeneration.
Brain. 2025;148:493-505. PubMedAbstract available
January 2025
SAINBURG LE, Englot DJ, Morgan VL The impact of resective epilepsy surgery on the brain network: evidence from
post-surgical imaging.
Brain. 2025 Jan 24:awaf026. doi: 10.1093. PubMedAbstract available
CHAUVEAU L, Landeau B, Dautricourt S, Turpin AL, et al Anterior-temporal network hyperconnectivity is key to Alzheimer's disease: from
ageing to dementia.
Brain. 2025 Jan 15:awaf008. doi: 10.1093. PubMedAbstract available
WIMBERLEY C, Thompson G Bridging peripheral and central inflammation with TSPO-PET: insights into
depression and beyond.
Brain. 2025 Jan 9:awae403. doi: 10.1093. PubMed
November 2024
DUONG MT, Das SR, Khandelwal P, Lyu X, et al Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer and Lewy
body disease.
Brain. 2024 Nov 22:awae352. doi: 10.1093. PubMedAbstract available
SAKATO Y, Shima A, Terada Y, Takeda K, et al Delineating three distinct spatiotemporal patterns of brain atrophy in
Parkinson's disease.
Brain. 2024;147:3702-3713. PubMedAbstract available
SPITZ G, Hicks AJ, McDonald SJ, Dore V, et al Plasma biomarkers in chronic single moderate-severe traumatic brain injury.
Brain. 2024;147:3690-3701. PubMedAbstract available
October 2024
KATSUMI Y, Howe IA, Eckbo R, Wong B, et al Default mode network tau predicts future clinical decline in atypical early
Alzheimer's disease.
Brain. 2024 Oct 16:awae327. doi: 10.1093. PubMedAbstract available
BANWINKLER M, Dzialas V, Rigoux L, Asendorf AL, et al Putaminal dopamine modulates movement motivation in Parkinson's disease.
Brain. 2024;147:3352-3357. PubMedAbstract available
D'ANGREMONT E, van der Zee S, Slingerland S, Slomp AC, et al Cholinergic deficiency in Parkinson's disease patients with visual
hallucinations.
Brain. 2024;147:3370-3378. PubMedAbstract available
September 2024
ABANTO J, Dwivedi AK, Imbimbo BP, Espay AJ, et al Increases in amyloid-beta42 slow cognitive and clinical decline in Alzheimer's
disease trials.
Brain. 2024 Sep 11:awae216. doi: 10.1093. PubMedAbstract available
July 2024
APPLETON J, Finn Q, Zanotti-Fregonara P, Yu M, et al Brain inflammation co-localizes highly with tau in mild cognitive impairment due
to early-onset Alzheimer's disease.
Brain. 2024 Jul 16:awae234. doi: 10.1093. PubMedAbstract available
DEVULDER A, Vanderlinden G, Van Langenhoven L, Testelmans D, et al Epileptic activity on foramen ovale electrodes is associated with sleep and tau
pathology in Alzheimer's disease.
Brain. 2024 Jul 11:awae231. doi: 10.1093. PubMedAbstract available
NILSSON J, Pichet Binette A, Palmqvist S, Brum WS, et al Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum
of neurodegenerative diseases.
Brain. 2024;147:2414-2427. PubMedAbstract available
June 2024
PERETTI DE, Boccalini C, Ribaldi F, Scheffler M, et al Association of glial fibrillary acid protein, Alzheimer's disease pathology and
cognitive decline.
Brain. 2024 Jun 28:awae211. doi: 10.1093. PubMedAbstract available
ROEMER SN, Brendel M, Gnoerich J, Malpetti M, et al Subcortical tau is linked to hypoperfusion in connected cortical regions in
4-repeat tauopathies.
Brain. 2024 Jun 6:awae174. doi: 10.1093. PubMedAbstract available
May 2024
ALTMANN A, Aksman LM, Oxtoby NP, Young A, et al Towards cascading genetic risk in Alzheimer's disease.
Brain. 2024 May 31:awae176. doi: 10.1093. PubMedAbstract available
TETZLOFF KA, Martin PR, Duffy JR, Utianski RL, et al Longitudinal flortaucipir, metabolism and volume differ between phonetic and
prosodic speech apraxia.
Brain. 2024;147:1696-1709. PubMedAbstract available
CROWLEY SJ, Kanel P, Roytman S, Bohnen NI, et al Basal forebrain integrity, cholinergic innervation and cognition in idiopathic
Parkinson's disease.
Brain. 2024;147:1799-1808. PubMedAbstract available
April 2024
CODY KA, Langhough RE, Zammit MD, Clark L, et al Characterizing brain tau and cognitive decline along the amyloid timeline in
Alzheimer's disease.
Brain. 2024 Apr 26:awae116. doi: 10.1093. PubMedAbstract available
WANG YT, Therriault J, Servaes S, Tissot C, et al Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster
tangle accumulation in females.
Brain. 2024;147:1497-1510. PubMedAbstract available
March 2024
DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al Longitudinal associations of serum biomarkers with early cognitive, amyloid and
grey matter changes.
Brain. 2024;147:936-948. PubMedAbstract available
February 2024
YANG HS, Yau WW, Carlyle BC, Trombetta BA, et al Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical
Alzheimer's disease.
Brain. 2024 Feb 5:awae034. doi: 10.1093. PubMedAbstract available
January 2024
HERRANZ E, Treaba CA, Barletta VT, Mehndiratta A, et al Characterization of cortico-meningeal translocator protein expression in multiple
sclerosis.
Brain. 2024 Jan 30:awae030. doi: 10.1093. PubMedAbstract available
BAGNATO F, Sati P, Hemond CC, Elliott C, et al Imaging chronic active lesions in multiple sclerosis: a consensus statement.
Brain. 2024 Jan 16:awae013. doi: 10.1093. PubMedAbstract available
December 2023
SCHUMACHER J, Kanel P, Dyrba M, Storch A, et al Structural and molecular cholinergic imaging markers of cognitive decline in
Parkinson's disease.
Brain. 2023;146:4964-4973. PubMedAbstract available
November 2023
SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al Characteristics of amnestic patients with hypometabolism patterns suggestive of
Lewy body pathology.
Brain. 2023;146:4520-4531. PubMedAbstract available
October 2023
LAURENCIN C, Lancelot S, Brosse S, Merida I, et al Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine
PET/neuromelanin MRI study.
Brain. 2023 Oct 3:awad338. doi: 10.1093. PubMedAbstract available
September 2023
BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al Determinants of cognitive and brain resilience to tau pathology: a longitudinal
analysis.
Brain. 2023;146:3719-3734. PubMedAbstract available
COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al Genetically identical twin-pair difference models support the amyloid cascade
hypothesis.
Brain. 2023;146:3735-3746. PubMedAbstract available
July 2023
AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al A data-driven study of Alzheimer's disease related amyloid and tau pathology
progression.
Brain. 2023 Jul 11:awad232. doi: 10.1093. PubMedAbstract available